Optiscan has been featured in the Sydney Morning Herald, The Age, and Brisbane Times following the announcement of its successful completion of the Minimum Viable Product (MVP) for its cloud-based telepathology platform.

The article outlines how Optiscan’s platform, developed in partnership with Canadian firm Prolucid Technologies, enables real-time, remote collaboration between clinicians and pathologists—streaming high-resolution images securely during surgery or diagnostic procedures.

“This platform is a potential game changer for global digital pathology, with particular relevance to regional, rural and remote healthcare settings where access to pathology expertise is limited. Our telepathology solution essentially brings the pathologist into the heart of the operating theatre and bridges the gap between surgery and pathology,” said Dr. Camile Farah, Optiscan CEO. 

This breakthrough supports faster clinical decision-making and helps overcome geographic barriers in pathology—further advancing Optiscan’s mission to transform healthcare with real-time digital imaging.

Read The Age full article here.

Read the Sydney Morning Herald full article here.

Read the Brisbane Times full article here.

Read the Bulls N' Bears full article here.